Company Monitoring Page for Shire

latest headlines for company on cafepharma

Is Shire’s Drug In Trouble Even After Allergan’s Legal Defeat?
Bidness, ETC
Wed, 03/30/16 - 12:17 pm
Tags:
Shire, Allergan, Lialda, patents
Shire prevails in Lialda patent case against Allergan
BioPharma Dive
Tue, 03/29/16 - 11:18 am
Tags:
Shire, Lialda, Allergan, patents, Watson, ulcerative colitis
Baxter to further trim stake in Baxalta ahead of $32B Shire buyout
Mass Device
Thu, 03/17/16 - 04:57 pm
Tags:
Baxter, Baxalta, M&A, Shire, devices
Could Biogen and Shire merge? ​One blogger lays out the case
Bizjournals.com
Mon, 03/7/16 - 09:52 pm
Tags:
Biogen, Shire, M&A
Sanofi scouts for rare disease buyouts as Shire bears down on the field
Fierce Biotech
Tue, 03/1/16 - 09:37 am
Tags:
Sanofi, Shire, M&A, R&D, Biomarin, Ionis Pharmaceuticals, Ultragenyx
Allergan execs see Restasis withstanding rivalry with prospective Shire med
Fierce Pharma Marketing
Wed, 02/24/16 - 10:50 am
Tags:
Allergan, Shire, Restasis, Lifitegrast, dry eye disease
With Baxalta in hand, Shire's not looking to buy. But sell? Maybe
Fierce Pharma
Thu, 02/11/16 - 08:59 pm
Tags:
Baxalta, Shire, M&A, Vyvanse
Shire posts better-than-expected 13 pct rise in Q4 earnings
Yahoo/Reuters
Thu, 02/11/16 - 08:31 am
Tags:
Shire, earnings
Baxalta drops, CTI nosedives after patient deaths & adverse events prompt FDA partial hold
BioPharma Dive
Mon, 02/8/16 - 10:24 am
Tags:
Baxalta, Shire, CTI BioPharma, pacritinib, JAK inhibitors
Shire's self-described blockbuster eye drug lines up for FDA do-over
Fierce Biotech
Sat, 02/6/16 - 12:18 pm
Tags:
Shire, dry eye disease, FDA, Lifitegrast
Shire's back on track with its dry-eye threat to Allergan's Restasis
Fierce Pharma Marketing
Wed, 01/27/16 - 10:25 am
Tags:
Shire, dry eye disease, Allergan, Restasis, Lifitegrast
Shire gets back on track with once-rejected eye drug
Fierce Biotech
Mon, 01/25/16 - 10:51 am
Tags:
Shire, Lifitegrast, dry eye disease
Shire Completes Acquisition of Dyax
Yahoo
Fri, 01/22/16 - 10:06 am
Tags:
Shire, Dyax, M&A
How Shire can Fuel Another Pfizer-Allergan Type Deal
Bidness, ETC
Thu, 01/21/16 - 05:43 pm
Tags:
Shire, M&A, Pfizer, Allergan, Baxalta, tax inversions
Shire-Baxalta Inc Deal: Benefits Outweigh Risks
Bidness, ETC
Tue, 01/19/16 - 08:13 am
Tags:
Shire, Baxalta, M&A
Shire, Baxalta Merger is Now Street-Approved: Here’s Why
Bidness, ETC
Sat, 01/16/16 - 11:29 am
Tags:
Shire, Baxalta, M&A
Shire CEO thinks he can beat $500M in postmerger cost savings
Fierce Pharma
Thu, 01/14/16 - 10:13 am
Tags:
Shire, Pharma CEOs, Flemming Ornskov, Baxalta, M&A
Shire's Baxalta Acquisition: An Orphan Drugs Market Dream?
Forbes
Wed, 01/13/16 - 10:45 am
Tags:
Shire, Baxalta, M&A, orphan drugs
Shire says internal synergy goals from Baxalta deal higher
Yahoo/Reuters
Tue, 01/12/16 - 09:16 pm
Tags:
Shire, Baxalta, M&A
Why Shire-Baxalta Merger Failed To Excite Investors
Bidness, ETC
Tue, 01/12/16 - 08:26 am
Tags:
Shire, Baxalta, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.